Location History:
- Chikaltana, IN (2003 - 2004)
- Aurangabad, IN (2005)
Company Filing History:
Years Active: 2003-2005
Title: The Innovative Contributions of Rupinder K Beri
Introduction
Rupinder K Beri is a notable inventor based in Chikaltana, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. With a total of 3 patents to her name, her work has the potential to impact medical treatments significantly.
Latest Patents
One of her latest patents is focused on the generation of triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives. This invention relates to new generation compounds that include their optical isomers, diastereomers, or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs, and pseudopolymorphs. The preparation, compositions, and use of these compounds as medicaments are also covered in this patent.
Another significant patent involves chiral fluoroquinolone arginine salt forms. This invention pertains to new arginine salt forms of S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid. It includes a process for their preparation and pharmaceutical formulations that utilize these arginine salt forms as the active ingredient for treating antimicrobial infections.
Career Highlights
Rupinder K Beri is currently associated with Wockhardt Limited, a prominent pharmaceutical company. Her work at Wockhardt has allowed her to focus on innovative solutions in the field of medicine.
Collaborations
She has collaborated with notable colleagues such as Mahesh Vithalbhai Patel and Satish B Bhawsar, contributing to a dynamic research environment that fosters innovation.
Conclusion
Rupinder K Beri's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a significant inventor. Her work continues to pave the way for advancements in antimicrobial treatments.